Johns Hopkins University (JHU) - SciVal Experts v3.6

66 Publications

This is a list of publications by this researcher, listed chronologically starting with the most recent first. New publications appear in this list weekly. The source of publications for this application is PubMed, so only PubMed publications are included.

Select All |

Export to Endnote

1.
2012

Judith E Karp; Elizabeth Garrett-Mayer; Elihu H Estey; Michelle A Rudek; B Douglas Smith; Jacqueline M Greer; D Michelle Drye; Karen Mackey; Kathleen Shannon Dorcy; Steven D Gore; et al.

Randomized phase II study of two schedules of flavopiridol given as timed sequential therapy with cytosine arabinoside and mitoxantrone for adults with newly diagnosed, poor-risk acute myelogenous leukemia.
Haematologica 2012;97(11):1736-42.
2.
2012

Jeffrey J Pu; Rong Hu; Galina L Mukhina; Hetty E Carraway; Michael A McDevitt; Robert A Brodsky

The small population of PIG-A mutant cells in myelodysplastic syndromes do not arise from multipotent hematopoietic stem cells.
Haematologica 2012;97(8):1225-33.
3.
2012

Amer M Zeidan; Rebecca M Ricklis; Hetty E Carraway; Hyun D Yun; Jacqueline M Greer; B Douglas Smith; Mark J Levis; Michael A McDevitt; Keith W Pratz; Margaret M Showel; et al.

Phase 1 dose-escalation trial of clofarabine followed by escalating dose of fractionated cyclophosphamide in adults with relapsed or refractory acute leukaemias.
British journal of haematology 2012;158(2):198-207.
4.
2012

Andres Jerez; Yuka Sugimoto; Hideki Makishima; Amit Verma; Anna M Jankowska; Bartlomiej Przychodzen; Valeria Visconte; Ramon V Tiu; Christine L O'Keefe; Azim M Mohamedali; et al.

Loss of heterozygosity in 7q myeloid disorders: clinical associations and genomic pathogenesis.
Blood 2012;119(25):6109-17.
5.
2012

Andres Jerez; Lukasz P Gondek; Anna M Jankowska; Hideki Makishima; Bartlomiej Przychodzen; Ramon V Tiu; Christine L O'Keefe; Azim M Mohamedali; Denise Batista; Mikkael A Sekeres; et al.

Topography, clinical, and genomic correlates of 5q myeloid malignancies revisited.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(12):1343-9.
6.
2012

Michael A McDevitt

Clinical applications of epigenetic markers and epigenetic profiling in myeloid malignancies.
Seminars in oncology 2012;39(1):109-22.
7.
2012

Judith E Karp; Tatiana I Vener; Mitch Raponi; Ellen K Ritchie; B Douglas Smith; Steven D Gore; Lawrence E Morris; Eric J Feldman; Jacqueline M Greer; Sami Malek; et al.

Multi-institutional phase 2 clinical and pharmacogenomic trial of tipifarnib plus etoposide for elderly adults with newly diagnosed acute myelogenous leukemia.
Blood 2012;119(1):55-63.
8.
2012

Chris Cheadle; Alan E Berger; Stephen C Mathai; Dmitry N Grigoryev; Tonya N Watkins; Yumiko Sugawara; Sangjucta Barkataki; Jinshui Fan; Meher Boorgula; Laura Hummers; et al.

Erythroid-specific transcriptional changes in PBMCs from pulmonary hypertension patients.
PloS one 2012;7(4):e34951.
9.
2011

Anna M Jankowska; Hideki Makishima; Ramon V Tiu; Hadrian Szpurka; Yun Huang; Fabiola Traina; Valeria Visconte; Yuka Sugimoto; Courtney Prince; Christine O'Keefe; et al.

Mutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX, EZH2, and DNMT3A.
Blood 2011;118(14):3932-41.
10.
2011

Brady L Stein; Donna M Williams; Christine O'Keefe; Ophelia Rogers; Roxann G Ingersoll; Jerry L Spivak; Amit Verma; Jarek P Maciejewski; Michael A McDevitt; Alison R Moliterno

Disruption of the ASXL1 gene is frequent in primary, post-essential thrombocytosis and post-polycythemia vera myelofibrosis, but not essential thrombocytosis or polycythemia vera: analysis of molecular genetics and clinical phenotypes.
Haematologica 2011;96(10):1462-9.
11.
2011

Amy E DeZern; Anthony Sung; Sharon Kim; B Douglas Smith; Judith E Karp; Steven D Gore; Richard J Jones; Ephraim Fuchs; Leo Luznik; Michael McDevitt; et al.

Role of allogeneic transplantation for FLT3/ITD acute myeloid leukemia: outcomes from 133 consecutive newly diagnosed patients from a single institution.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2011;17(9):1404-9.
12.
2011

Jin Kyun Park; Allan C Gelber; Gang Zheng; Michael A McDevitt; Christopher D Gocke; Alan N Baer

Large-vessel vasculitis as an early manifestation of chronic myelomonocytic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(20):e601-3.
13.
2011

Hideki Makishima; Anna M Jankowska; Michael A McDevitt; Christine O'Keefe; Simon Dujardin; Heather Cazzolli; Bartlomiej Przychodzen; Courtney Prince; John Nicoll; Harish Siddaiah; et al.

CBL, CBLB, TET2, ASXL1, and IDH1/2 mutations and additional chromosomal aberrations constitute molecular events in chronic myelogenous leukemia.
Blood 2011;117(21):e198-206.
14.
2011

Javier Bolaños-Meade; B Douglas Smith; Steven D Gore; Michael A McDevitt; Leo Luznik; Ephraim J Fuchs; Richard J Jones

5-azacytidine as salvage treatment in relapsed myeloid tumors after allogeneic bone marrow transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2011;17(5):754-8.
15.
2011

Ramon V Tiu; Lukasz P Gondek; Christine L O'Keefe; Paul Elson; Jungwon Huh; Azim Mohamedali; Austin Kulasekararaj; Anjali S Advani; Ronald Paquette; Alan F List; et al.

Prognostic impact of SNP array karyotyping in myelodysplastic syndromes and related myeloid malignancies.
Blood 2011;117(17):4552-60.
16.
2011

Youl-Nam Lee; Stephanie Brandal; Pierre Noel; Erik Wentzel; Joshua T Mendell; Michael A McDevitt; Reuben Kapur; Melody Carter; Dean D Metcalfe; Clifford M Takemoto

KIT signaling regulates MITF expression through miRNAs in normal and malignant mast cell proliferation.
Blood 2011;117(13):3629-40.
17.
2011

Judith E Karp; B Douglas Smith; Linda S Resar; Jacqueline M Greer; Amanda Blackford; Ming Zhao; Dwella Moton-Nelson; Katrina Alino; Mark J Levis; Steven D Gore; et al.

Phase 1 and pharmacokinetic study of bolus-infusion flavopiridol followed by cytosine arabinoside and mitoxantrone for acute leukemias.
Blood 2011;117(12):3302-10.
18.
2010

H Makishima; A M Jankowska; R V Tiu; H Szpurka; Y Sugimoto; Z Hu; Y Saunthararajah; K Guinta; M A Keddache; P Putnam; et al.

Novel homo- and hemizygous mutations in EZH2 in myeloid malignancies.
Leukemia 2010;24(10):1799-804.
19.
2010

Elizabeth A Griffiths; Steven D Gore; Craig M Hooker; Helai P Mohammad; Michael A McDevitt; B Douglas Smith; Judith E Karp; James G Herman; Hetty E Carraway

Epigenetic differences in cytogenetically normal versus abnormal acute myeloid leukemia.
Epigenetics : official journal of the DNA Methylation Society 2010;5(7):590-600.
20.
2010

Elizabeth A Griffiths; Steven D Gore; Craig Hooker; Michael A McDevitt; Judith E Karp; B Douglas Smith; Helai P Mohammad; Ying Ye; James G Herman; Hetty E Carraway

Acute myeloid leukemia is characterized by Wnt pathway inhibitor promoter hypermethylation.
Leukemia & lymphoma 2010;51(9):1711-9.
21.
2010

K W Pratz; E Cho; M J Levis; J E Karp; S D Gore; M McDevitt; A Stine; M Zhao; S D Baker; M A Carducci; et al.

A pharmacodynamic study of sorafenib in patients with relapsed and refractory acute leukemias.
Leukemia 2010;24(8):1437-44.
22.
2010

Judith E Karp; Amanda Blackford; B Douglas Smith; Katrina Alino; Amy Hatfield Seung; Javier Bolaños-Meade; Jacqueline M Greer; Hetty E Carraway; Steven D Gore; Richard J Jones; et al.

Clinical activity of sequential flavopiridol, cytosine arabinoside, and mitoxantrone for adults with newly diagnosed, poor-risk acute myelogenous leukemia.
Leukemia research 2010;34(7):877-82.
23.
2010

Michael A McDevitt

The Erg-onomics of myeloproliferation in Down syndrome.
Blood 2010;115(19):3859-60.
24.
2010

Clifford M Takemoto; Stephanie Brandal; Anil G Jegga; Youl-Nam Lee; Amir Shahlaee; Ye Ying; Rodney Dekoter; Michael A McDevitt

PU.1 positively regulates GATA-1 expression in mast cells.
Journal of immunology (Baltimore, Md. : 1950) 2010;184(8):4349-61.
25.
2010

Christine O'Keefe; Michael A McDevitt; Jaroslaw P Maciejewski

Copy neutral loss of heterozygosity: a novel chromosomal lesion in myeloid malignancies.
Blood 2010;115(14):2731-9.
26.
2010

Jungwon Huh; Ramon V Tiu; Lukasz P Gondek; Christine L O'Keefe; Monika Jasek; Hideki Makishima; Ania M Jankowska; Ying Jiang; Amit Verma; Karl S Theil; et al.

Characterization of chromosome arm 20q abnormalities in myeloid malignancies using genome-wide single nucleotide polymorphism array analysis.
Genes, chromosomes & cancer 2010;49(4):390-9.
27.
2010

M Jasek; L P Gondek; N Bejanyan; R Tiu; J Huh; K S Theil; C O'Keefe; M A McDevitt; J P Maciejewski

TP53 mutations in myeloid malignancies are either homozygous or hemizygous due to copy number-neutral loss of heterozygosity or deletion of 17p.
Leukemia 2010;24(1):216-9.
28.
2010

Evan J Lipson; Carol Ann Huff; Danniele G Holanda; Michael A McDevitt; Derek M Fine

Lenalidomide-induced acute interstitial nephritis.
The oncologist 2010;15(9):961-4.
29.
2009

Hideki Makishima; Heather Cazzolli; Hadrian Szpurka; Andrew Dunbar; Ramon Tiu; Jungwon Huh; Hideki Muramatsu; Christine O'Keefe; Eric Hsi; Ronald L Paquette; et al.

Mutations of e3 ubiquitin ligase cbl family members constitute a novel common pathogenic lesion in myeloid malignancies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(36):6109-16.
30.
2009

Brian Garibaldi; Rupal Malani; Hsin-Chieh Yeh; Evan Lipson; Deborah Michell; Mosi Bennett; Alison Moliterno; Michael A McDevitt; Thomas S Kickler

Estimating platelet production in patients with HIV-related thrombocytopenia using the immature platelet fraction.
American journal of hematology 2009;84(12):852-4.
31.
2009

Ramon V Tiu; Lukasz P Gondek; Christine L O'Keefe; Jungwon Huh; Mikkael A Sekeres; Paul Elson; Michael A McDevitt; Xiao Fei Wang; Mark J Levis; Judith E Karp; et al.

New lesions detected by single nucleotide polymorphism array-based chromosomal analysis have important clinical impact in acute myeloid leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(31):5219-26.
32.
2009

Ying Ye; Michael A McDevitt; Mingzhou Guo; Wei Zhang; Oliver Galm; Steven D Gore; Judith E Karp; Jaroslaw P Maciejewski; Jeanne Kowalski; Hua-Ling Tsai; et al.

Progressive chromatin repression and promoter methylation of CTNNA1 associated with advanced myeloid malignancies.
Cancer research 2009;69(21):8482-90.
33.
2009

Toyoko Hiroi; Clayton B Deming; Haige Zhao; Baranda S Hansen; Elisabeth K Arkenbout; Thomas J Myers; Michael A McDevitt; Jeffrey J Rade

Proteasome inhibitors enhance endothelial thrombomodulin expression via induction of Krüppel-like transcription factors.
Arteriosclerosis, thrombosis, and vascular biology 2009;29(10):1587-93.
34.
2009

Anna M Jankowska; Hadrian Szpurka; Ramon V Tiu; Hideki Makishima; Manuel Afable; Jungwon Huh; Christine L O'Keefe; Rebecca Ganetzky; Michael A McDevitt; Jaroslaw P Maciejewski

Loss of heterozygosity 4q24 and TET2 mutations associated with myelodysplastic/myeloproliferative neoplasms.
Blood 2009;113(25):6403-10.
35.
2008

Andrew J Dunbar; Lukasz P Gondek; Christine L O'Keefe; Hideki Makishima; Manjot S Rataul; Hadrian Szpurka; Mikkael A Sekeres; Xiao Fei Wang; Michael A McDevitt; Jaroslaw P Maciejewski

250K single nucleotide polymorphism array karyotyping identifies acquired uniparental disomy and homozygous mutations, including novel missense substitutions of c-Cbl, in myeloid malignancies.
Cancer research 2008;68(24):10349-57.
36.
2008

Jason E Farrar; Michelle Nater; Emi Caywood; Michael A McDevitt; Jeanne Kowalski; Clifford M Takemoto; C Conover Talbot; Paul Meltzer; Diane Esposito; Alan H Beggs; et al.

Abnormalities of the large ribosomal subunit protein, Rpl35a, in Diamond-Blackfan anemia.
Blood 2008;112(5):1582-92.
37.
2008

Clifford M Takemoto; Youl-Nam Lee; Anil G Jegga; Daniella Zablocki; Stephanie Brandal; Amir Shahlaee; Suming Huang; Ying Ye; Sivakumar Gowrisankar; Jimmy Huynh; et al.

Mast cell transcriptional networks.
Blood cells, molecules & diseases 2008;41(1):82-90.
38.
2008

Jonathan K Alder; Robert W Georgantas; Richard L Hildreth; Ian M Kaplan; Sebastien Morisot; Xiaobing Yu; Michael McDevitt; Curt I Civin

Kruppel-like factor 4 is essential for inflammatory monocyte differentiation in vivo.
Journal of immunology (Baltimore, Md. : 1950) 2008;180(8):5645-52.
39.
2007

Judith E Karp; Rebecca M Ricklis; Kumudha Balakrishnan; Janet Briel; Jacqueline Greer; Steven D Gore; B Douglas Smith; Michael A McDevitt; Hetty Carraway; Mark J Levis; et al.

A phase 1 clinical-laboratory study of clofarabine followed by cyclophosphamide for adults with refractory acute leukemias.
Blood 2007;110(6):1762-9.
40.
2007

K Eric Paulson; Kimberly Rieger-Christ; Michael A McDevitt; Charlotte Kuperwasser; Jiyoung Kim; Vincent E Unanue; Xiaowei Zhang; Maowen Hu; Robin Ruthazer; Stephen P Berasi; et al.

Alterations of the HBP1 transcriptional repressor are associated with invasive breast cancer.
Cancer research 2007;67(13):6136-45.
41.
2007

M A McDevitt; M Condon; J Stamberg; J E Karp; M McDiarmid

Fluorescent in situ hybridization (FISH) in bone marrow and peripheral blood of leukemia patients: implications for occupational surveillance.
Mutation research 2007;629(1):24-31.
42.
2007

Lukasz P Gondek; Andrew J Dunbar; Hadrian Szpurka; Michael A McDevitt; Jaroslaw P Maciejewski

SNP array karyotyping allows for the detection of uniparental disomy and cryptic chromosomal abnormalities in MDS/MPD-U and MPD.
PloS one 2007;2(11):e1225.
43.
2006

Xiaowei Zhang; Jiyoung Kim; Robin Ruthazer; Michael A McDevitt; David E Wazer; K Eric Paulson; Amy S Yee

The HBP1 transcriptional repressor participates in RAS-induced premature senescence.
Molecular and cellular biology 2006;26(22):8252-66.
44.
2006

Michael A McDevitt; Jianlin Xie; Ganapathy Shanmugasundaram; Jason Griffith; Aihua Liu; Courtney McDonald; Philip Thuma; Victor R Gordeuk; Christine N Metz; Robert Mitchell; et al.

A critical role for the host mediator macrophage migration inhibitory factor in the pathogenesis of malarial anemia.
The Journal of experimental medicine 2006;203(5):1185-96.
45.
2005

Rebecca C Osthus; Baktiar Karim; Julia E Prescott; B Douglas Smith; Michael McDevitt; David L Huso; Chi V Dang

The Myc target gene JPO1/CDCA7 is frequently overexpressed in human tumors and has limited transforming activity in vivo.
Cancer research 2005;65(13):5620-7.
46.
2004

Kamaleldin E Elagib; Mang Xiao; Isa M Hussaini; Lorrie L Delehanty; Lisa A Palmer; Frederick K Racke; Michael J Birrer; Ganapath Shanmugasundaram; Michael A McDevitt; Adam N Goldfarb

Jun blockade of erythropoiesis: role for repression of GATA-1 by HERP2.
Molecular and cellular biology 2004;24(17):7779-94.
47.
2004

Amy S Yee; Eric K Paulson; Michael A McDevitt; Kimberly Rieger-Christ; Ian Summerhayes; Stephen P Berasi; Jiyoung Kim; Chun-Yin Huang; Xiaowei Zhang

The HBP1 transcriptional repressor and the p38 MAP kinase: unlikely partners in G1 regulation and tumor suppression.
Gene 2004;336(1):1-13.
48.
2004

Michael A McDevitt; Jianlin Xie; Victor Gordeuk; Richard Bucala

The anemia of malaria infection: role of inflammatory cytokines.
Current hematology reports 2004;3(2):97-106.
49.
2003

Marianne E Greene; Gina Mundschau; Joshua Wechsler; Michael McDevitt; Alan Gamis; Judith Karp; Sandeep Gurbuxani; Robert Arceci; John D Crispino

Mutations in GATA1 in both transient myeloproliferative disorder and acute megakaryoblastic leukemia of Down syndrome.
Blood cells, molecules & diseases 2003;31(3):351-6.
50.
2002

Joshua Wechsler; Marianne Greene; Michael A McDevitt; John Anastasi; Judith E Karp; Michelle M Le Beau; John D Crispino

Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome.
Nature genetics 2002;32(1):148-52.
51.
1999

P Vyas; M A McDevitt; A B Cantor; S G Katz; Y Fujiwara; S H Orkin

Different sequence requirements for expression in erythroid and megakaryocytic cells within a regulatory element upstream of the GATA-1 gene.
Development (Cambridge, England) 1999;126(12):2799-811.
52.
1998

S H Orkin; R A Shivdasani; Y Fujiwara; M A McDevitt

Transcription factor GATA-1 in megakaryocyte development.
Stem cells (Dayton, Ohio) 1998;16 Suppl 2():79-83.
53.
1997

M A McDevitt; Y Fujiwara; R A Shivdasani; S H Orkin

An upstream, DNase I hypersensitive region of the hematopoietic-expressed transcription factor GATA-1 gene confers developmental specificity in transgenic mice.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(15):7976-81.
54.
1997

R A Shivdasani; Y Fujiwara; M A McDevitt; S H Orkin

A lineage-selective knockout establishes the critical role of transcription factor GATA-1 in megakaryocyte growth and platelet development.
The EMBO journal 1997;16(13):3965-73.
55.
1997

M A McDevitt; R A Shivdasani; Y Fujiwara; H Yang; S H Orkin

A "knockdown" mutation created by cis-element gene targeting reveals the dependence of erythroid cell maturation on the level of transcription factor GATA-1.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(13):6781-5.
56.
1993

E John; M L Thakur; J DeFulvio; M R McDevitt; I Damjanov

Rhenium-186-labeled monoclonal antibodies for radioimmunotherapy: preparation and evaluation.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1993;34(2):260-7.
57.
1992

M L Thakur; J DeFulvio; J Tong; E John; M R McDevitt; I Damjanov

Evaluation of biological response modifiers in the enhancement of tumor uptake of technetium-99m labeled macromolecules. A preliminary report.
Journal of immunological methods 1992;152(2):209-16.
58.
1988

G M Gilmartin; M A McDevitt; J R Nevins

Multiple factors are required for specific RNA cleavage at a poly(A) addition site.
Genes & development 1988;2(5):578-87.
59.
1988

M A McDevitt; G M Gilmartin; W H Reeves; J R Nevins

Multiple factors are required for poly(A) addition to a mRNA 3' end.
Genes & development 1988;2(5):588-97.
60.
1987

G Galli; J W Guise; M A McDevitt; P W Tucker; J R Nevins

Relative position and strengths of poly(A) sites as well as transcription termination are critical to membrane versus secreted mu-chain expression during B-cell development.
Genes & development 1987;1(5):471-81.
61.
1986

M A McDevitt; R P Hart; W W Wong; J R Nevins

Sequences capable of restoring poly(A) site function define two distinct downstream elements.
The EMBO journal 1986;5(11):2907-13.
62.
1985

R P Hart; M A McDevitt; J R Nevins

Poly(A) site cleavage in a HeLa nuclear extract is dependent on downstream sequences.
Cell 1985;43(3 Pt 2):677-83.
63.
1985

R P Hart; M A McDevitt; H Ali; J R Nevins

Definition of essential sequences and functional equivalence of elements downstream of the adenovirus E2A and the early simian virus 40 polyadenylation sites.
Molecular and cellular biology 1985;5(11):2975-83.
64.
1984

M A McDevitt; M J Imperiale; H Ali; J R Nevins

Requirement of a downstream sequence for generation of a poly(A) addition site.
Cell 1984;37(3):993-9.
65.
1984

A G Goodridge; R A Jenik; M A McDevitt; S M Morris; L K Winberry

Malic enzyme and fatty acid synthase in the uropygial gland and liver of embryonic and neonatal ducklings. Tissue-specific regulation of gene expression.
Archives of biochemistry and biophysics 1984;230(1):82-92.
66.
1982

S M Morris; J H Nilson; R A Jenik; L K Winberry; M A McDevitt; A G Goodridge

Molecular cloning of gene sequences for avian fatty acid synthase and evidence for nutritional regulation of fatty acid synthase mRNA concentration.
The Journal of biological chemistry 1982;257(6):3225-9.

A Michael Mcdevitt
The Johns Hopkins University, School of Medicine

A Michael Mcdevitt

66 Publications

A Michael Mcdevitt The Johns Hopkins University, School of Medicine

A Michael Mcdevitt

66 Publications

A Michael Mcdevitt
The Johns Hopkins University, School of Medicine